Vontobel Holding’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Vontobel Holding's ADPT Position: Q3 2026 in Review
Vontobel Holding reduced its Adaptive Biotechnologies (ADPT) stake by 2.9% in Q3 2026, selling an estimated $12.3K and leaving 16,500 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.
Vontobel Holding first reported a position in ADPT in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.62M in Q3 2021. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Vontobel Holding held 16,500 shares of Adaptive Biotechnologies worth $477K as of Q3 2026.
- Vontobel Holding sold 500 Adaptive Biotechnologies shares in Q3 2026, an estimated $12.3K.
- Adaptive Biotechnologies made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1082 holding.
- Vontobel Holding first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 15 quarters since.
- Vontobel Holding's Adaptive Biotechnologies position peaked at $1.62M in Q3 2021.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.